Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Test Could Detect Infection Exposure History

By LabMedica International staff writers
Posted on 02 Feb 2026

Every infection leaves a lasting imprint on the immune system, but current diagnostic tools can usually detect exposure to only one pathogen at a time. More...

This makes it difficult to understand a person’s full infection history or immune protection using a simple test. Because immune responses vary widely between individuals, this diagnostic potential remains largely untapped. Researchers are now working toward a blood-based approach that could reconstruct lifelong exposure to infections by reading immune cell signatures.

T-cells detect infections through highly specific surface sensors known as T-cell receptors, each designed to bind a particular antigen. When a matching antigen is encountered, the corresponding T-cells multiply rapidly. While most die after clearing the infection, a subset remains as memory T-cells, preserving a record of that encounter. Researchers at the University of Erlangen-Nuremberg (FAU, Erlangen, Germany), in collaboration with the University Hospital Erlangen (Erlangen, Germany), have shown that exposure to a pathogen leads to the expansion of many T-cell clones, creating detectable patterns in the blood.

Although individual T-cell receptors differ greatly between people, infections often generate shared or even identical receptor sequences across multiple individuals. These recurring patterns form what researchers describe as an immunological fingerprint. By comparing T-cell receptor sequences from individuals with confirmed past infections, the team aims to identify receptor features specific to particular pathogens. Machine learning algorithms will be used to analyze these large datasets and link receptor patterns to known infectious diseases.

The researchers are initially focusing on viruses that can cause complications during pregnancy, such as rubella. One goal is to assess whether vaccinated or previously infected individuals, including pregnant women, still retain protective immunity by analyzing their T-cell profiles. This approach could complement or even extend beyond traditional antibody-based serological tests. In the long term, the team plans to build libraries of pathogen-specific T-cell receptors and contribute to a global database. This could allow a single blood test to provide a comprehensive overview of an individual’s infection history and immune status across their lifetime.

“Each infection leaves a trace in the immune system. For example, if you have ever had the flu, you will have more T-cells whose receptors match the flu virus antigens than someone who has not.” said Professor Kilian Schober, PhD, lead investigator. “In future, a single test may be sufficient to illustrate an individual’s infection history over their entire lifetime.”

Related Links:
FAU
University Hospital Erlangen


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.